KIR2DL4 and cancer: However, there are a series of KIRs based immunotherapy strategies that can provide new insights into future cancer immunotherapies targeting KIR2DL4, such as immune checkpoint blockade (ICB) therapy, adoptive cell transfer (ACT) therapy and small-molecule inhibitors [44].